Testing effectiveness (Phase 2)UnknownNCT04631757
What this trial is testing
Conversion Therapy of Camrelizumab Plus Chemoradiotherapy in Participants With Initial Unresectable Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma
Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 33